Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Nooruzzaman M, Johnson KE, Rani R, Finkelsztein EJ, Caserta LC, Kodiyanplakkal RP, et al. Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections. medRxiv. 2024.

Galbraith K, Serrano J, Shen G, Tran I, Slocum CC, Ketchum C, et al. Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors. Mol Cancer Res. 2024;22(1):21-28.

Ohara K, Rendeiro AF, Bhinder B, Eng KW, Ravichandran H, Nguyen D, et al. The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis. Nat Commun. 2024;15(1):2009.

Daman AW, Antonelli AC, Redelman-Sidi G, Paddock L, Cheong JG, Jurado LF, et al. Microbial cancer immunotherapy reprograms hematopoietic stem cells to enhance anti-tumor immunity. bioRxiv. 2024.

Cavallaro J, Singha S, Chakrabarti B, Gopalakrishnan E, Harshan M, Pramanik BK, et al. Symptomatic infratentorial ependymal cyst arising from the medulla: a case report with review of literature. Neurochirurgie. 2024;70(4):101553.

Xu X, Feng J, Wang X, Zeng X, Luo Y, He X, et al. Mitochondrial GRIM19 Loss Induces Liver Fibrosis through NLRP3/IL33 Activation via Reactive Oxygen Species/NF-кB Signaling. J Clin Transl Hepatol. 2024;12(6):539-550.

Kubiak JM, Klevay M, Hilt EE, Ferrieri P. Acute Meningoencephalitis Associated with Borrelia miyamotoi, Minnesota, USA. Emerg Infect Dis. 2024;30(7):1472-1474.

Morales AE, Gumenick R, Genovese CM, Jang YY, Ouedraogo A, de Garayo MI, et al. Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP. PLoS Pathog. 2024;20(1):e1011881.

Morse KW, Sun J, Hu L, Bok S, Debnath S, Cung M, et al. Development of Murine Anterior Interbody and Posterolateral Spinal Fusion Techniques. J Bone Joint Surg Am. 2024.

Deng Q, Lakra P, Gou P, Yang H, Meydan C, Teater M, et al. SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions. Cancer Cell. 2024.